Back to Results
First PageMeta Content
3 / 4-Diaminopyridine / Pyridines / Lambert–Eaton myasthenic syndrome / BioMarin Pharmaceutical / Small-cell carcinoma / NHS Constitution for England / National Health Service / Scottish Medicines Consortium / NHS Scotland / Medicine / Health / Paraneoplastic syndromes


Document Date: 2013-08-13 12:09:51

Open Document

File Size: 204,67 KB

Share Result on Facebook

Company

BioMarin UK Ltd. / /

Country

United Kingdom / /

Currency

GBP / /

Event

FDA Phase / /

IndustryTerm

chemical neuro transmitter / Treatment of Lambert-Eaton Myasthenic Syndrome / /

MedicalCondition

cancers / numbness / excessive fatigue / SCLC / especially small-cell lung cancer / cancer / autoimmune disorder / learning disability / chronic progressive debilitating condition / constipation / muscle weakness / Lambert-Eaton Myasthenic Syndrome / /

Organization

NHSCB Board / European Medicines Agency / NHS / Commissioning Board / /

Person

Lambert-Eaton Myasthenic / /

Product

Amifampridine 10mg / D04/PS / /

Technology

antibodies / pdf / /

URL

http /

SocialTag